Fig. 3.
Fig. 3. Overall survival of ALK-positive lymphomas expressing NPM-ALK (n = 44), variant ALK fusion protein(s) (“x-ALK”) (n = 15), and ALK-negative anaplastic large-cell lymphomas (n = 25).

Overall survival of ALK-positive lymphomas expressing NPM-ALK (n = 44), variant ALK fusion protein(s) (“x-ALK”) (n = 15), and ALK-negative anaplastic large-cell lymphomas (n = 25).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal